Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor (VAS-kyoo-ler EN-duh-THEE-lee-ul . Rih-SEP-ter TY-ruh-seen KY-nayz In-HIH-bih-ter) at Medical Drugs Glossary
What is Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor (VAS-kyoo-ler EN-duh-THEE-lee-ul . Rih-SEP-ter TY-ruh-seen KY-nayz In-HIH-bih-ter)? VEGFR tyrosine kinase inhibitor. A substance that blocks an enzyme needed to form blood vessels.Medical Term & Definition Added By: Brody
The Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor (VAS-kyoo-ler EN-duh-THEE-lee-ul . Rih-SEP-ter TY-ruh-seen KY-nayz In-HIH-bih-ter) definition has been viewed 291 Time(s)!
Send To Friends!
If you'd like to send the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor (VAS-kyoo-ler EN-duh-THEE-lee-ul . Rih-SEP-ter TY-ruh-seen KY-nayz In-HIH-bih-ter) definition to yourself or to your friends/colleagues, just enter the e-mail addresses in the boxes below -We hope you now understand the meaning of Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor (VAS-kyoo-ler EN-duh-THEE-lee-ul . Rih-SEP-ter TY-ruh-seen KY-nayz In-HIH-bih-ter). If you need any more information on this term, please don't hesitate to contact us.
Other Similar Drugs Terms:
Prescription Drugs Term Flow field effect (flowFET) is A technology utilized in the design of microfluidics systems that utilizes field effects to control flow.Prescription Drugs Term chronic granulocytic leukemia is A slowly progressing disease in which too many white blood cells (not lymphocytes) are made in the bone marrow. Also called chronic myelogenous leukemia or chronic myeloid leukemia.
Prescription Drugs Term tin ethyl etiopurpurin is An anticancer drug that is also used in cancer prevention. It belongs to the family of drugs called photosensitizing agents. Also called SnET2.
Prescription Drugs Term Myeloma is A tumor caused by the proliferation of immunoglobulin-synthesizing cells. Myelomas produce large amounts of a single (monoclonal) antibody, or the individual heavy or light chains.
Prescription Drugs Term Antibody combining site is The antigen (epitope) recognition and binding site of an antibody. The variable regions of both heavy and light chains contribute to the antibody combining site.